Table 3 The subjective symptoms of vaginal atrophy and dyspareunia before and after intervention in the oxytocin and placebo groups
Variables | Dyspareunia | Oxytocin n = 44 | Placebo n = 42 | P value using Mann Whitney U test | P value using GEE |
|---|---|---|---|---|---|
N(%) | |||||
Before intervention | Negative | 2 (4.5) | 2 (4.8) | ||
Mild | 13 (9.5) | 12 (28.6) | 0.514 | ||
Moderate | 14 (31.8) | 9 (21.4) | |||
Severe | 15 (34.1) | 19 (45.2) | |||
Two weeks after intervention | Negative | 9 (20.5) | 2 (4.8) | ||
Mild | 19 (43.2) | 13 (31) | < 0.001 | < 0.0001 | |
Moderate | 13 (29.5) | 9 (21.4) | |||
Severe | 3 (6.8) | 18 (42.9) | |||
Eight weeks after intervention | Negative | 39 (88.6) | 3 (7.1) | ||
Mild | 5 (11.4) | 19 (45.2) | < 0.001 | ||
Moderate | 0 | 13 (31) | |||
Severe | 0 | 7 (16.7) | |||